LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
5.45
-0.15 (-2.68%)
At close: Mar 28, 2025, 4:00 PM
5.27
-0.18 (-3.30%)
Pre-market: Mar 31, 2025, 8:39 AM EDT
LifeMD Revenue
In the year 2024, LifeMD had annual revenue of $212.45M with 39.27% growth. LifeMD had revenue of $64.25M in the quarter ending December 31, 2024, with 43.23% growth.
Revenue (ttm)
$212.45M
Revenue Growth
+39.27%
P/S Ratio
1.06
Revenue / Employee
$692,032
Employees
307
Market Cap
242.98M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 212.45M | 59.91M | 39.27% |
Dec 31, 2023 | 152.55M | 33.51M | 28.15% |
Dec 31, 2022 | 119.03M | 26.16M | 28.16% |
Dec 31, 2021 | 92.88M | 55.58M | 149.04% |
Dec 31, 2020 | 37.29M | 24.83M | 199.10% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
LFMD News
- 5 days ago - LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - GlobeNewsWire
- 20 days ago - LifeMD, Inc. (LFMD) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 20 days ago - LifeMD Reports Fourth Quarter 2024 Results - GlobeNewsWire
- 24 days ago - Telehealth firms Teladoc, LifeMD tie up with Eli Lilly's pharmacy partner to offer Zepbound - Reuters
- 25 days ago - LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound - GlobeNewsWire
- 26 days ago - LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum - GlobeNewsWire
- 4 weeks ago - LifeMD to Report Fourth Quarter 2024 Financial Results on March 10 - GlobeNewsWire
- 4 weeks ago - LifeMD® Announces Entry Into the Behavioral Health Market - GlobeNewsWire